SULT genetic polymorphisms: physiological, pharmacological and clinical implications. (3rd July 2021)

• Record Type: Journal Article
• Authors: Kurogi, Katsuhisa; Rasool, Mohammed I.; Alherz, Fatemah A.; El Daibani, Amal A.; Bairam, Ahsan F.; Abunnaja, Maryam S.; Yasuda, Shin; Wilson, Lauren J.; Hui, Ying; Liu, Ming-Cheh
• Is Part Of: Expert opinion on drug metabolism and toxicology. Volume 17:Number 7(2021)
• Page Start: 767
• Page End: 784
• Publication Date: 2021-07-03
• Subjects: Cytosolic sulfotransferase -- SULT -- sulfation -- single-nucleotide polymorphism -- SNP; Drugs -- Toxicology -- Periodicals; Drugs -- Metabolism -- Periodicals; 615.7
• DOI: 10.1080/17425255.2021.1940952
• Languages: English
• ISSNs: 1742-5255

Abstract

Abstract: Introduction: Cytosolic sulfotransferases (SULTs)-mediated sulfation is critically involved in the metabolism of key endogenous compounds, such as catecholamines and thyroid/steroid hormones, as well as a variety of drugs and other xenobiotics. Studies performed in the past three decades have yielded a good understanding about the enzymology of the SULTs and their structural biology, phylogenetic relationships, tissue/organ-specific/developmental expression, as well as the regulation of the SULT gene expression. An emerging area is related to the functional impact of the SULT genetic polymorphisms. Areas covered: The current review aims to summarize our current knowledge about the above-mentioned aspects of the SULT research. An emphasis is on the information concerning the effects of the polymorphisms of the SULT genes on the functional activity of the SULT allozymes and the associated physiological, pharmacological, and clinical implications. Expert opinion: Elucidation of how SULT SNPs may influence the drug-sulfating activity of SULT allozymes will help understand the differential drug metabolism and eventually aid in formulating personalized drug regimens. Moreover, the information concerning the differential sulfating activities of SULT allozymes toward endogenous compounds may allow for the development of strategies for mitigating anomalies in the metabolism of these endogenous compounds in individuals with certain SULT genotypes.